2 min read
Examining mutations in the SARS-CoV-2 Spike (S) Protein Receptor Binding Domain (RBD) at the ACE2 receptor S protein interface
Topics: News Insights Covid SARS-CoV-2
6 min read
Conformational change of the spike protein furin cleavage domain may enhance virus infectivity
June 16, 2020 (Santa Clara, Calif.) — Research by two U.S.-based antibody discovery companies shows a rise and dominance of a mutant SARS-CoV-2 virus and identifies a new mechanism predicting a competitive advantage of the mutation. The mutation is predicted to induce a structural change in the spike protein of the virus that would enhance virus entry. The study, conducted by Antibody Solutions and Single Cell Technology (SCT), is available on Preprints.org (the study’s findings have not yet been peer-reviewed).
Topics: News Covid SARS-CoV-2 Molecuar Modeling
1 min read
On March 31, 2020, California Gov. Gavin Newsom extended the statewide shelter-in-place order through May 3, 2020. Additional restrictions designed to help protect citizens from the COVID-19 pandemic also were imposed.
Consistent with the March 19 order, this order considers life science companies such as Antibody Solutions to be “essential,” meaning we are exempt from many restrictions imposed on other businesses and can continue our operations. As specified in this order, we are preparing an updated document formalizing the social distancing protocol we had implemented in accordance with the first order.
1 min read
On March 19, 2020, California Gov. Gavin Newsom announced statewide requirements in light of the COVID-19 pandemic. These required actions in this order align with the Santa Clara County shelter-in-place orders released earlier this week and have not imposed any additional restrictions on Antibody Solutions operations. We will continue to monitor this situation and provide updates, as necessary.
On March 16, 2020, the Public Health Department of Santa Clara County, California, along with five other San Francisco Bay Area counties, issued a shelter-in-place order for all county residents in response to the COVID-19 pandemic. That includes us here at Antibody Solutions.
3 min read
Antibody Solutions’ Grand Opening Celebration | 01.30.20
From sparkling selfies and twirling mobiles of antibodies to insightful speeches, facility tours and tasty tacos, Antibody Solutions’ Grand Opening celebration last week had a little bit of everything. And we couldn’t be prouder!(*)
More than 125 treasured clients, partners and their families came together for what could be--and was—an evening of fun, festivity and friendship. We held the event to commemorate both our new 33,300-square-foot facility in Santa Clara, Calif., and the kickoff to our Silver Anniversary. The theme for our event was “25 Years of Revealing the Future,” and it was especially wonderful to welcome many guests who’ve been with us through the decades.
2 min read
Expanded Partnership Offers Antibody Solutions Clients Access to the Transgenic H2L2 Harbour Mice™ Platform
Agreement Provides for Easy Access to the Transgenic H2L2 Harbour Mice™ Platform with Antibody Solutions’ Discovery and Development Services
2 min read
Antibody Solutions Announces Partnership with SCT at 2017 Antibody Engineering & Therapeutics Conference
Antibody Solutions, a leader in discovery of therapeutic, biomarker and critical reagent antibodies, and Single Cell Technology, Inc. (SCT), a pioneer in single cell analysis technology, have launched a partnership that offers pharmaceutical researchers one-stop access to advanced single B-cell antibody discovery capabilities.